Cyclo Therapeutics Announces Allowance of Patent from European Patent Office for Trappsol Cyclo for Alzheimer's Disease
12.06.2023 - Cyclo Therapeutics, Inc. (Nasdaq: CYTH) (“Cyclo Therapeutics” or the “Company”), a clinical stage biotechnology company dedicated to developing life-changing medicines through science and innovation for patients and families living with diseases, ...
Source: wallstreet-online.de